Related Experiment Video
Updated: Jul 10, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Robust estimation and testing of haplotype effects in case-control studies.
Andrew S Allen1, Glen A Satten
1Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina 27710, USA. andrews.s.allen@duke.edu
Genetic Epidemiology
|October 20, 2007
Summary
This study introduces novel statistical estimators for disease-haplotype association analysis. These methods are robust to uncertainty in haplotype phase, improving parameter estimates in genetic studies.
Area of Science:
- Genetics
- Statistical genetics
- Computational biology
Background:
- Haplotype-based analyses are crucial for understanding complex diseases.
- Existing statistical methods for disease-haplotype association often struggle with uncertain haplotype phase from genotype data.
- Misspecification of haplotype distribution models can bias parameter estimates.
Purpose of the Study:
- To develop novel statistical estimators for disease-haplotype association.
- To create estimators robust to haplotype distribution misspecification.
- To address challenges posed by uncertain haplotype phase in genetic data.
Main Methods:
- Utilized score functions derived from likelihoods.
- Applied the efficient score approach for estimation in the presence of nuisance parameters.
- Developed novel estimators robust to haplotype distribution variations.
- Investigated empirical performance through simulations.
Main Results:
- Introduced novel estimators that are robust to haplotype distribution misspecification.
- Demonstrated the theoretical underpinnings and relationships between these estimators.
- Empirical simulations validated the performance of the proposed methods.
Conclusions:
- The novel estimators offer a robust approach to disease-haplotype association studies.
- These methods mitigate bias arising from haplotype ambiguity and distribution misspecification.
- The findings contribute to more reliable genetic analyses of complex diseases.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:16Statistical Hypothesis Testing
Hypothesis testing is a critical statistical procedure facilitating informed, evidence-based decisions. It begins with a hypothesis, which is a tentative explanation, or a prediction about a population parameter. This hypothesis can be either a null hypothesis (H0), indicating no effect or difference, or an alternative hypothesis (Ha), suggesting an effect or difference.
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
Statistical significance measures the probability that an observed result occurred by chance. If this probability, known as...
01:23Test for Homogeneity
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can be stated as...
01:13Accuracy and Errors in Hypothesis Testing
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...